• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

    6.886 +0.066 (+0.97%)
    Streaming Delayed Price Updated: 10:05 AM EDT, Aug 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20,485
    Open 6.750
    Bid (Size) 6.530 (100)
    Ask (Size) 6.910 (100)
    Prev. Close 6.820
    Today's Range 6.283 - 6.970
    52wk Range 3.350 - 17.94
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Law Offices of Howard G. Smith Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -47.8%
    -47.8%
    1 Month
    +9.0%
    +9.0%
    3 Month
    +64.0%
    +64.0%
    6 Month
    -45.3%
    -45.3%
    1 Year
    -23.8%
    -23.8%

    More News

    Read More
    News headline image
    Law Offices of Frank R. Cruz Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders to Inquire About Securities Fraud Class Action
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD
    From The DJS Law Group
    Via Business Wire
    News headline image
    AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via Business Wire
    News headline image
    Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD
    From Levi & Korsinsky, LLP
    Via Business Wire
    News headline image
    AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Securities Fraud Investigation Into Aardvark Therapeutics, Inc. (AARD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Aardvark Therapeutics, Inc. (AARD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Investors of Aardvark Therapeutics, Inc. (NASDAQ: AARD) to Contact the Firm to Learn About Their Legal Rights
    Via NewMediaWire
    Topics Initial Public Offering Lawsuit
    News headline image
    AARD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aardvark Therapeutics, Inc.
    From Robbins LLP
    Via Business Wire
    News headline image
    Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action
    From Robbins LLP
    Via Business Wire
    News headline image
    Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
    From Aardvark Therapeutics, Inc.
    Via GlobeNewswire
    Unusual volume stocks in Monday's session ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD
    From Pomerantz LLP
    Via GlobeNewswire
    Here are the top movers in Friday's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    These stocks are moving in today's pre-market session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?
    Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?
    The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market
    What is the current price of Aardvark Therapeutics, Inc. - Common Stock?
    The current price of Aardvark Therapeutics, Inc. - Common Stock is 6.886
    When was Aardvark Therapeutics, Inc. - Common Stock last traded?
    The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 08/24/26 10:05 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.